These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 21187503)

  • 21. [Approaches for interventional therapy of hepatoma].
    Guan YS; Yang L
    Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):785. PubMed ID: 16248956
    [No Abstract]   [Full Text] [Related]  

  • 22. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation.
    Yao FY; Hirose R; LaBerge JM; Davern TJ; Bass NM; Kerlan RK; Merriman R; Feng S; Freise CE; Ascher NL; Roberts JP
    Liver Transpl; 2005 Dec; 11(12):1505-14. PubMed ID: 16315294
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Hepatocellular carcinoma: local-regional treatment].
    Fleig WE
    Dtsch Med Wochenschr; 2003 Jun; 128 Suppl 2():S102-3. PubMed ID: 12817337
    [No Abstract]   [Full Text] [Related]  

  • 24. Predictive factors for distant recurrence of HCV-related hepatocellular carcinoma after radiofrequency ablation combined with chemoembolization.
    Fuke H; Sugimoto K; Shiraki K; Tanaka J; Beppu T; Yoneda K; Yamamoto N; Ito K; Takaki H; Nakatsuka A; Yamakado K; Takeda K; Takei Y
    Aliment Pharmacol Ther; 2008 Jun; 27(12):1253-60. PubMed ID: 18221404
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemoembolization for hepatocellular carcinoma in cirrhotic patients: assessment of efficacy on total hepatectomy specimens.
    Duvoux C; Cherqui D; Van Nhieu JT; Vavasseur D; Zafrani ES; Mathieu D; Fagniez PL; Dhumeaux D
    Transplant Proc; 1994 Dec; 26(6):3572-3. PubMed ID: 7527981
    [No Abstract]   [Full Text] [Related]  

  • 27. Combined transcatheter arterial chemoembolization and beta-ultrasound guided portal vein embolization in the treatment of hepatocellular carcinoma.
    Mao G; Yu Z; Zhang Y; Cheng J
    Zhonghua Zhong Liu Za Zhi; 2002 Jul; 24(4):391-3. PubMed ID: 12408773
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxorubicin-eluting bead-enhanced radiofrequency ablation of hepatocellular carcinoma: a pilot clinical study.
    Lencioni R; Crocetti L; Petruzzi P; Vignali C; Bozzi E; Della Pina C; Bargellini I; Cioni D; Oliveri F; De Simone P; Bartolozzi C; Brunetto M; Filipponi F
    J Hepatol; 2008 Aug; 49(2):217-22. PubMed ID: 18486261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A phase I/II trial of chemoembolization for hepatocellular carcinoma using a novel intra-arterial drug-eluting bead.
    Poon RT; Tso WK; Pang RW; Ng KK; Woo R; Tai KS; Fan ST
    Clin Gastroenterol Hepatol; 2007 Sep; 5(9):1100-8. PubMed ID: 17627902
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Study of local three-dimensional conformal radiotherapy combined with transcatheter arterial chemoembolization for patients with stage III hepatocellular carcinoma.
    Li B; Yu J; Wang L; Li C; Zhou T; Zhai L; Xing L
    Am J Clin Oncol; 2003 Aug; 26(4):e92-9. PubMed ID: 12902905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preoperative chemoembolization in patients with hepatocellular carcinoma undergoing liver transplantation: influence of emergent versus elective procedures on patient survival and tumor recurrence rate.
    Stockland AH; Walser EM; Paz-Fumagalli R; McKinney JM; May GR
    Cardiovasc Intervent Radiol; 2007; 30(5):888-93. PubMed ID: 17619218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Role of post-operative transcatheter arterial chemoembolization in hepatocellular carcinoma with different pathological characteristics].
    Xi T; Yan ZL; Wang K; Li J; Xia Y; Shen F; Wu MC
    Zhonghua Wai Ke Za Zhi; 2007 May; 45(9):587-90. PubMed ID: 17688789
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple intrahepatic implantations of hepatocellular carcinoma following percutaneous ethanol injection (PEI) therapy.
    Petsas T; Kalogeropoulou C; Tsota I; Tsamandas AC
    Liver Int; 2006 Apr; 26(3):382-4. PubMed ID: 16584403
    [No Abstract]   [Full Text] [Related]  

  • 34. A critical appraisal of the literature on local ablative therapies for hepatocellular carcinoma.
    Lencioni R; Crocetti L
    Clin Liver Dis; 2005 May; 9(2):301-14, viii. PubMed ID: 15831275
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Controlled clinical trial of doxorubicin and tamoxifen versus doxorubicin alone in hepatocellular carcinoma.
    Melia WM; Johnson PJ; Williams R
    Cancer Treat Rep; 1987 Dec; 71(12):1213-6. PubMed ID: 2446752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combination therapy with radiofrequency ablation and transcatheter chemoembolization for the treatment of hepatocellular carcinoma: Short-term recurrences and survival.
    Yamakado K; Nakatsuka A; Akeboshi M; Shiraki K; Nakano T; Takeda K
    Oncol Rep; 2004 Jan; 11(1):105-9. PubMed ID: 14654911
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastrointestinal Elimination of a Hepatocellular Carcinoma.
    Kissane J; Waybill P
    J Vasc Interv Radiol; 2018 Jun; 29(6):883. PubMed ID: 29798760
    [No Abstract]   [Full Text] [Related]  

  • 38. Combined ethanol injection therapy and radiofrequency ablation therapy in percutaneous treatment of hepatocellular carcinoma larger than 4 cm.
    Vallone P; Catalano O; Izzo F; Siani A
    Cardiovasc Intervent Radiol; 2006; 29(4):544-51. PubMed ID: 16528626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [The results of the chemoembolization of advanced hepatocellular carcinomas. The effect on the survival times, morphological findings and tumor markers].
    Wickenhöfer R; Hasan I; Schüller H; Reiser M; Hartlapp JH
    Rofo; 1992 Apr; 156(4):328-32. PubMed ID: 1373966
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Changes of immune function in liver cancer patients after transcatheter arterial chemoembolizaton combined with interstitial therapy].
    Quan Y; Liu JG; Cai YC; Zhang JR
    Nan Fang Yi Ke Da Xue Xue Bao; 2009 Nov; 29(11):2288-90. PubMed ID: 19923089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.